Alnylam Pharmace. buy Chardan Capital
Summary
This prediction ended on 17.02.25 with a price of €246.40. The BUY prediction by Chardan_Capital for Alnylam Pharmace. saw massive gains of 77.27%. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -25.387% | -25.387% | -48.093% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
25.03.26
25.03.27
31.07.26
Stopped prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
31.07.26
31.07.27
31.07.26
Alnylam Pharmace.
02.05.25
02.05.26
03.05.26
Alnylam Pharmace.
26.02.25
26.02.26
27.02.26
Alnylam Pharmace.
11.10.24
11.10.25
12.10.25
Alnylam Pharmace.
08.08.23
08.08.24
09.08.24

